Publications

Christian A. Lechtenböhmer, Thomas Hügle et al: Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis Arthritis Research & Therapy, October 2021

Catherine Raptis, Diego Andrey, Christoph Berger et al.:
Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases ACR, October 2021
Poster, October 2021

Enriqueta Vallejo-Yagüe, Andrea M. Burden, Theresa Burkard et al.: Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland MDPI, July 2021
Lay Summary

Michael J. Nissen , Burkhard Möller, Adrian Ciurea, et al.: Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors Arthritis Research & Therapy, June 2021

Ulf Lindström, Michael Nissen et al.: Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration Annals of the Rheumatic Diseases, June 2021

Diego Kyburz, Ulrich A Walker, Adrian Ciurea et al.: Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors RMD Open, April 2021

Yomei Shaw, Axel Finckh, Ulrich A Walker, Adrian Ciurea et al.: Impact of assessing patient- reported outcomes with mobile apps on patient– provider interaction Rheumatology (Oxford), March 2021

Michael J Nissen, Matthias Jarlborg, Axel Finckh et al.: Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis Rheumatology (Oxford), January 2021

Brigitte Michelsen, Michael Nissen, Burkhard Möller et al.: Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries Arthritis Care & Research, January 2021

Céline Lamacchia, Zuleika Calderin Sollet, Axel Finckh et al.: Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease Rheumatology, December 2020

Regula Neuenschwander, Adrian Ciurea, et al.: Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort Arthritis Research & Therapy, October 2020

Adrian Ciurea, Axel Finckh, et al.: Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort [Annals in Rheumatic Diseases, September 2020](https://ard.bmj.com/content/annrheumdis/early/2020/09/22/annrheumdis-2020-218705.full.pdf

Adrian Ciurea, Michael Nissen et al.: Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration RMD Open, august 2020

Delphine S Courvoisier, Axel Finckh, et al.: The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries Rheumatology, August 2020

Raphael Micheroli, Adrian Ciurea et al.: Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort. Annals in Rheumatic Diseases, June 2020

Matthias Jarlborg, Michael Nissen et al.: Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Research and Therapy, May 2020

Axel Finckh, Pascal Zufferey et al.: Comparative Effectiveness of Antitumour Necrosis Factor Agents, Biologics With an Alternative Mode of Action and Tofacitinib in an Observational Cohort of Patients With Rheumatoid Arthritis in Switzerland. RMD Open, May 2020

Matthew Thomas, Burkhard Moeller et al.: Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases. The Journal of Rheumatology April 2020

Monika Hebeisen, Adrian Ciurea et al.: Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. Plos One, March 2020

Brigitte Michelsen, Adrian Ciurea et al.: Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatology, January 2020